Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Martek Biosciences---- future biotech cash cow! -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (120)	1/7/1998 8:11:00 AM
From: Machaon	Read Replies (1) \| Respond to of 258

<< Good product, lousy business plan? >> I had sold my shares of MATK, but got back in, after they hired the two heavy-weights from Merck, for the "business" side of the company. They didn't seem to be making significant progress in the infant formula area, which should be the driving force for profitability, IMHO. But, their recent personnel changes have made me very positive about Martek's future. This info was released in October, 97. ===================================================================== "Ivan Rubin, former Vice President of Business Planning, Development, and Research for Merck & Company, will be working with Martek as Director of Business Development and Strategic Planning. Mr. Rubin played a major role in developing the strategies to position Merck as a leader in the pharmaceutical industry. Mr. Rubin will join Jerome Keller, Martek's Senior Vice President of Sales and Marketing, and former Vice President of Merck Sales in the U.S., to commercialize Martek's nutritional products." ===================================================================== Hopefully, we'll see a news release, in the near future, showing the effects, on Martek's business plan, as a result of their addition to Martek's staff. It's been too quiet. They've had about 3 months to come up with something. It would be unusual, in my mind, for Rubin and Keller not to have something cooking by now. << and I've seen at least one report of another algae-derived DHA >> Thanks for the info. Do you remember what company was mentioned in the report? I'm going to do a little searching for the info. I'd like to know how close the others are to commercialization. It's important to know how much of a head start Martek has on the competition. Regards, Bob